首页> 美国卫生研究院文献>Cancers >Micronutrient Synergy in the Fight against Hepatocellular Carcinoma
【2h】

Micronutrient Synergy in the Fight against Hepatocellular Carcinoma

机译:微量元素协同作用抗击肝细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The incidence of hepatocellular carcinoma (HCC), once thought to be a rare tumor in North America, has rapidly increased in recent years in the United States. Current treatment modalities to halt the progression of this disease are only marginally effective. The mainstay treatment is liver transplantation, which is often confronted with donor shortage. Invasion, metastasis and recurrence contribute to the high mortality rate of this disease. Matrix metalloproteinases (MMPs) that degrade the extracellular matrix (ECM) have been associated with the progression, invasion and metastasis of the disease. We have developed strategies to strengthen the ECM collagen and inhibit MMPs through micronutrients such as lysine, proline and ascorbic acid. Addition of epigallocatechin gallate or green tea extract to these micronutrients synergistically enhanced anti-carcinogenic activity in HepG2 cells. Addition of certain other micronutrients, such as N-acetylcysteine, selenium, copper and zinc (NM) synergistically enhanced the anticancer activity of the mixture in a model of hepatocellular carcinoma using HepG2 cells. In vitro studies using HepG2 demonstrated that NM was very effective in inhibiting cell proliferation (by MTT assay), MMPs secretion (by gelatinase zymography), cell invasion (through Matrigel) and induction of apoptosis (by live green caspase). In addition, NM was shown to down-regulate urokinase plasminogen activator (by fibrin zymography) and up-regulate tissue inhibitors of metalloproteinases (by reverse zymography) in another HCC cell line, SK-Hep-1. MMP-2 and MMP-9 activities were further modulated by phorbol 12-myristate 13-acetate (PMA) induction and inhibited by NM. In previous studies, NM inhibited Sk-Hep-1 xenografts in nude mice and also inhibited hepatic metastasis of B16FO melanoma cells. Our results suggest that NM is an excellent candidate for therapeutic use in the treatment HCC by inhibiting critical parameters in cancer development and progression, such as proliferation, invasion and metastasis, and by inducing apoptosis.
机译:肝细胞癌(HCC)曾经被认为是北美罕见的肿瘤,近年来在美国迅速上升。阻止该疾病进展的当前治疗方式仅勉强有效。主要的治疗方法是肝移植,这经常面临供体短缺的问题。入侵,转移和复发导致该疾病的高死亡率。降解细胞外基质(ECM)的基质金属蛋白酶(MMP)与疾病的进展,侵袭和转移有关。我们已经制定了通过微营养素(例如赖氨酸,脯氨酸和抗坏血酸)来增强ECM胶原蛋白并抑制MMP的策略。向这些微量营养素中添加表没食子儿茶素没食子酸酯或绿茶提取物可协同增强HepG2细胞的抗癌活性。在使用HepG2细胞的肝细胞癌模型中,添加某些其他微量营养素(例如N-乙酰半胱氨酸,硒,铜和锌(NM))可协同增强混合物的抗癌活性。使用HepG2进行的体外研究表明,NM在抑制细胞增殖(通过MTT分析),MMP分泌(通过明胶酶酶谱分析),细胞入侵(通过Matrigel)和诱导凋亡(通过活的绿色胱天蛋白酶)方面非常有效。此外,在另一种HCC细胞系SK-Hep-1中,NM被证明下调了尿激酶纤溶酶原激活剂(通过纤维蛋白酶谱法),并上调了金属蛋白酶的组织抑制剂(通过反向酶谱法)。 MMP-2和MMP-9活性进一步受到佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)诱导的调节,并被NM抑制。在以前的研究中,NM抑制裸鼠的Sk-Hep-1异种移植,也抑制B16FO黑色素瘤细胞的肝转移。我们的结果表明,NM通过抑制癌症发展和进程中的关键参数(例如增殖,侵袭和转移)并诱导凋亡,是治疗HCC的极佳候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号